Indian authorities announced the detection of two cases of the Nipah virus since December in the state of West Bengal. The identified contacts have been quarantined and tested, with all 196 traced contacts testing negative. However, following the confirmation of cases in India, several Asian countries have intensified health controls at airports. Indonesia and Thailand have implemented security measures, including temperature checks and health declarations. Myanmar has advised against non-essential travel to West Bengal and has intensified medical surveillance for travelers. It indicated that fever surveillance, implemented during the COVID-19 pandemic at airports, has been intensified. Similarly, Vietnam's Ministry of Health urged the adoption of strict food safety practices and ordered local authorities to increase surveillance at border crossings, health facilities, and communities. Meanwhile, China stated that it is strengthening disease prevention measures in border areas. Chinese state media reported that health authorities had initiated risk assessments and improved training for medical personnel, as well as increasing monitoring and testing capacity, according to the Associated Press (AP).

Precautions and Treatments

Nipah (Henipavirus nipahense), a zoonotic virus first identified during an outbreak in Malaysia in the 1990s, is spread through fruit bats, pigs, and human-to-human contact. Known for its high mortality rate, there is no vaccine.

It can cause high fevers, seizures, and vomiting. Health authorities recommend supportive care to manage complications in patients.

The World Health Organization (WHO) warns that the virus's fatality rate ranges from 40% to 75%, exceeding that of the coronavirus.

Symptoms and differences with other diseases

Nipah virus causes initial flu-like symptoms, but progresses rapidly to serious complications such as encephalitis.

Initial symptoms. These appear 4-14 days after exposure and include fever, severe headache, muscle aches, nausea, vomiting, and sore throat.

Severe symptoms.

They progress to extreme drowsiness, mental confusion, disorientation, seizures, encephalitis (brain inflammation), pneumonia, respiratory distress, and possible coma within 24–48 hours. Unlike the common flu or COVID-19, which rarely cause acute encephalitis or rapid coma, Nipah is notable for its fulminant neurological progression and high lethality (40–75%), without the dominant initial respiratory symptoms seen in influenza. Unlike Ebola, it lacks massive hemorrhaging, focusing instead on brain and lung damage. Differential diagnosis requires PCR testing, as it mimics viral meningitis or dengue in its early stages. Context and Precedents of the Virus: Historically, the Nipah virus has affected India in previous outbreaks, particularly in West Bengal and Kerala. A significant outbreak in 2018 resulted in at least 17 deaths. Authorities are closely monitoring the situation to prevent further spread of the virus.

You may also be interested in:

· Goodbye to the WHO: What consequences will this have for US public health? · Following Canada's situation: The US is also about to lose its measles-free status